We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.94B
AUM Growth
-$6.24M
Cap. Flow
-$8.36M
Cap. Flow %
-0.43%
Top 10 Hldgs %
18.4%
Holding
264
New
14
Increased
88
Reduced
101
Closed
15

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$20.5M
2
CELH icon
Celsius Holdings
CELH
+$20M
3
AHCO icon
AdaptHealth
AHCO
+$19.3M
4
NOG icon
Northern Oil and Gas
NOG
+$18.9M
5
PRVA icon
Privia Health
PRVA
+$16.5M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$24.9M
2
AVNT icon
Avient
AVNT
+$21.7M
3
ONTO icon
Onto Innovation
ONTO
+$20M
4
ALKS icon
Alkermes
ALKS
+$19.3M
5
VC icon
Visteon
VC
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 30.67%
2 Industrials 16.05%
3 Consumer Discretionary 13.81%
4 Technology 13.49%
5 Financials 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
H icon
126
Hyatt Hotels
H
$17.6B
$1.51M 0.08%
18,675
+1,071
+6% +$91.1K
CVRX icon
127
CVRx
CVRX
$126M
$1.5M 0.08%
160,196
-187,300
-54% -$1.48M
AZO icon
128
AutoZone
AZO
$48.3B
$1.46M 0.08%
682
-6
-0.9% -$13.1K
HZNP
129
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.45M 0.08%
23,478
-8,526
-27% -$596K
PANW icon
130
Palo Alto Networks
PANW
$264B
$1.34M 0.07%
16,406
+1,832
+13% +$159K
AYX
131
DELISTED
Alteryx Inc
AYX
$1.33M 0.07%
23,852
-111
-0.5% -$6.51K
TTWO icon
132
Take-Two Interactive
TTWO
$43B
$1.28M 0.07%
11,739
+2,912
+33% +$362K
CMG icon
133
Chipotle Mexican Grill
CMG
$40.8B
$1.24M 0.06%
41,250
-250
-0.6% -$7.75K
AGS
134
DELISTED
PlayAGS
AGS
$1.23M 0.06%
231,267
+17,900
+8% +$108K
V icon
135
Visa
V
$677B
$1.23M 0.06%
6,901
– –
TJX icon
136
TJX Companies
TJX
$170B
$1.17M 0.06%
18,774
– –
TSLA icon
137
Tesla
TSLA
$1.24T
$1.02M 0.05%
3,855
– –
MTCH icon
138
Match Group
MTCH
$8.84B
$960K 0.05%
20,103
-98
-0.5% -$6.16K
CSGP icon
139
CoStar Group
CSGP
$11.3B
$954K 0.05%
13,700
-115
-0.8% -$7.98K
P
140
Everpure Inc
P
$24.8B
$908K 0.05%
33,161
-138
-0.4% -$3.9K
CVS icon
141
CVS Health
CVS
$137B
$895K 0.05%
9,385
+3
+0% +$297
MRVL icon
142
Marvell Technology
MRVL
$174B
$872K 0.05%
20,324
+12,210
+150% +$604K
MDB icon
143
MongoDB
MDB
$24B
$869K 0.04%
4,375
-21
-0.5% -$6.13K
UNH icon
144
UnitedHealth
UNH
$382B
$856K 0.04%
1,694
+195
+13% +$103K
LULU icon
145
lululemon athletica
LULU
$13B
$810K 0.04%
2,896
-22
-0.8% -$6.82K
ENPH icon
146
Enphase Energy
ENPH
$4.84B
$799K 0.04%
2,880
-463
-14% -$125K
FTNT icon
147
Fortinet
FTNT
$112B
$786K 0.04%
15,999
-131
-0.8% -$7.1K
MPB icon
148
Mid Penn Bancorp
MPB
$942M
$782K 0.04%
27,219
– –
ABT icon
149
Abbott
ABT
$180B
$752K 0.04%
7,772
+1,140
+17% +$122K
SIVB
150
DELISTED
SVB Financial Group
SIVB
$750K 0.04%
2,233
-1,115
-33% -$449K
4 5
6
7 8

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Emerald Advisers held 264 positions worth $1.94B, down 0.32% from $1.94B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers's Q3 2022 filing shows 14 new, 88 increased, 101 reduced and 15 closed positions. Its largest new stake was Blueprint Medicines: 318,574 shares worth $21M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $24.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Emerald Advisers's largest Q3 2022 buy was Blueprint Medicines: 318,574 shares worth $21M.
  • Emerald Advisers added most to AdaptHealth in Q3 2022, an estimated $19.3M increase.
  • Emerald Advisers's biggest Q3 2022 reduction was Avient, cutting an estimated $21.7M.
  • Emerald Advisers fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $24.9M.
  • Emerald Advisers's ten largest holdings make up 18% of its $1.94B portfolio in Q3 2022.
  • Emerald Advisers opened 14 new positions and closed 15 in Q3 2022.
  • Emerald Advisers's portfolio value fell 0.32% quarter-over-quarter to $1.94B.

Based on Emerald Advisers's 13F filing for Q3 2022, filed 25 Oct 2022.